May 8, 2024, Jackie Mogensen of Mother Jones interviewed Dr. Igor Grant about how DEA's potential rescheduling of marijuana from Schedule I to Schedule III may impact cannabis research. Dr. Grant, along with other scientists such as Staci Gruber, PhD (Harvard Medical School) Ziva Cooper, PhD (UCLA), and Margaret Haney, PhD (Columbia University Medical Center) who were interviewed for this article, were hopeful that rescheduling will decrease hurdles and improve the cannabis research landscape. Read what these researchers have to say about challenges of cannabis research and how rescheduling cannabis could help make it easier as well as encourage new researchers to get into the field.